What is erectile dysfunction?
Erectile dysfunction (ED) is “the inability to achieve or sustain an erection that is sufficient for satisfactory sexual performance.”[1] The prevalence of ED among adult males aged 40–79 has been estimated to be between 30% and 50%.[2][3]
Sexual stimulation normally causes the release of nitric oxide (NO) and acetylcholine (ACh) from nerve fibers in the penis, initiating a molecular signaling cascade that ultimately results in the relaxation of penile smooth muscle tissue, an elevation in blood flow, and tumescence (an erection). These processes are disrupted in ED. ED can be categorized as psychogenic ED or organic ED; the latter can be broadly characterized as neurogenic ED, vasculogenic ED, or iatrogenic (medication- or surgery-induced) ED.[1]
What are the main signs and symptoms of erectile dysfunction?
Men with ED are unable to achieve an erection when they want to, or can achieve an erection but are not able to sustain the erection long enough for sexual intercourse.
Signs of ED may include the presence of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) — both of which are associated with ED. Other signs of ED may include penile deformities, prostate disease, or hypogonadism (i.e., small testes or alterations in secondary sex characteristics).
Symptoms of organic ED include the consistent inability to achieve or sustain an erection; in organic ED, this inability is often gradual in onset, yet progressive in nature. Symptoms of psychogenic ED include ED that is more intermittent, variable, or situational. Psychogenic ED often has a sudden onset, and men with psychogenic ED tend to have more difficulty sustaining than achieving an erection.[1]
How is erectile dysfunction diagnosed?
The diagnosis of ED begins with a comprehensive evaluation including medical, sexual, and psychosocial history, a physical examination of genitourinary anatomy, and laboratory testing to rule out other conditions. Diagnosis and assessment of ED are also conducted using validated questionnaires such as the International Index of Erectile Function (IIEF), which assesses a patient’s response to various treatment strategies. The IIEF classifies ED into five categories: no ED (score of 22–25), mild ED (score of 17–21), mild-moderate ED (score of 12–16), moderate ED (score of 8–11), and severe ED (score of 1–7).[4]
In certain cases, specialized diagnostic testing, including vascular testing using ultrasound, nocturnal penile tumescence (NPT), erection rigidity testing, and neuropsychological testing, may be performed.[5]
What are some of the main medical treatments for erectile dysfunction?
The first-line therapy for ED is the use of a phosphodiesterase-5 inhibitor (PDE5I), of which sildenafil (Viagra), tadalafil, vardenafil, and avanafil are the most commonly prescribed. PDE5I in combination with prescription testosterone therapy has also been effective in improving ED symptoms.[6]
Other treatments for ED include the application of vasodilators like alprostadil (topical, intraurethral, or intracavernosal), low-intensity extracorporeal shockwave therapy (Li-ESWT), vacuum erection devices, testosterone therapy (intramuscular or transdermal), psychosexual counseling,cognitive behavioral therapy (CBT), vascular surgery, and the use of penile prostheses (inflatable or semirigid devices). Among these, the strongest evidence supports CBT (often in combination with PDE5Is), intracavernous alprostadil injections, and penile prosthesis implantation.[7]
Have any supplements been studied for erectile dysfunction?
Ginseng appears to have trivial effects on erectile function, but may improve men’s self-reported ability to have intercourse and their satisfaction with intercourse.[11] Saffron (Crocus sativus),[12] Tribulus terrestris,[13] Pycnogenol (Pinus pinaster),[14] Maca (Lepidium meyenii),[15] and Tongkat Ali (Eurycoma longifolia)[16] also appear to improve ED symptoms, though there are only a few studies to support each of these herbs.[17]
Supplementing with L-Arginine (alone or combined with L-Citrulline, Pycnogenol, ornithine, or yohimbine) improves erectile function.[18] Yohimbine, especially when combined with L-Arginine, also improves ED symptoms, but doesn’t seem to increase sexual function.[19] L-Citrulline (a precursor to L-Arginine) has also been shown in one study to improve erection hardness in men with ED.[20]
How could diet affect erectile dysfunction?
The Mediterranean diet, plant-based diets, and diets containing high amounts of fruits and vegetables, nuts, legumes, fish, whole grains, antioxidants, and omega-3 fatty acids and lower amounts of red and processed meat, trans fat, dairy, sugar, sodium, and alcohol are associated with a lower risk of ED.[21][22][23][24][25][26][27]
However, some studies suggest that any association between the type of diet one follows (i.e., Mediterranean, low-fat, low-carbohydrate, ketogenic, vegetarian/vegan, pescatarian) and ED disappears when controlling for age, BMI, and other risk factors.[28][29] Weight loss achieved through a low-fat, low-calorie diet;[30][31], a high-protein, low-carbohydrate diet;[32] a high-protein, low-fat diet; or a high-carbohydrate, low-fat diet[33] improves erectile function in men with diabetes and/or overweight/obesity.
Are there any other treatments for erectile dysfunction?
Weight loss, whether achieved through diet and/or physical activity[34][35][36] or through bariatric surgery,[37] improves ED in men with overweight or obesity.
Physical inactivity increases the risk for ED,[38][39] while exercise — particularly moderate- to vigorous-intensity aerobic exercise — improves erectile function in men with ED and comorbidities including obesity, metabolic syndrome, and cardiovascular disease.[40][41] In fact, a 2019 review indicated that among all ED treatments, physical activity interventions caused the largest improvement in ED, with effectiveness similar to pharmacological therapy.[42]
Other emerging yet experimental ED treatments include gene therapy, stem cell therapy,[43][44] Li-ESWT,[45][46][45] platelet-rich plasma (PRP), low-intensity pulsed ultrasound (LIPUS), hyperbaric oxygen therapy, penile vibratory stimulation,[47][48] and pelvic floor muscle training.[49].
What causes erectile dysfunction?
At its core, ED is caused by a deficit in NO release, cyclic GMP (cGMP) and calcium signaling, or smooth muscle relaxation. However, many overlapping mechanisms can interrupt this signaling cascade.
Psychogenic or sympathetic-mediated ED is caused by stress, depression, or anxiety about sexual performance. Neurogenic ED is caused by a deficit in nerve signaling to the penis, which may be secondary to spinal cord injury, traumatic brain injury, or surgery. Vasculogenic ED — the most common form of ED — is caused by underlying vascular disease, endothelial dysfunction, and structural changes to the arterial walls. Iatrogenic ED is most often the result of pelvic surgery or the use of medications. Finally, endocrine causes of ED include low levels of androgens (e.g., testosterone) and other hormones.
A number of medications have been linked to ED, including antihypertensives (blood pressure medications); 5𝛼-reductase inhibitors, anti-androgens, luteinizing hormone-releasing agonists and antagonists (used to treat prostate cancer), antidepressant medications, and opiates.[1]
Examine Database: Erectile Dysfunction
Research FeedRead all studies
Frequently asked questions
Erectile dysfunction (ED) is “the inability to achieve or sustain an erection that is sufficient for satisfactory sexual performance.”[1] The prevalence of ED among adult males aged 40–79 has been estimated to be between 30% and 50%.[2][3]
Sexual stimulation normally causes the release of nitric oxide (NO) and acetylcholine (ACh) from nerve fibers in the penis, initiating a molecular signaling cascade that ultimately results in the relaxation of penile smooth muscle tissue, an elevation in blood flow, and tumescence (an erection). These processes are disrupted in ED. ED can be categorized as psychogenic ED or organic ED; the latter can be broadly characterized as neurogenic ED, vasculogenic ED, or iatrogenic (medication- or surgery-induced) ED.[1]
Men with ED are unable to achieve an erection when they want to, or can achieve an erection but are not able to sustain the erection long enough for sexual intercourse.
Signs of ED may include the presence of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) — both of which are associated with ED. Other signs of ED may include penile deformities, prostate disease, or hypogonadism (i.e., small testes or alterations in secondary sex characteristics).
Symptoms of organic ED include the consistent inability to achieve or sustain an erection; in organic ED, this inability is often gradual in onset, yet progressive in nature. Symptoms of psychogenic ED include ED that is more intermittent, variable, or situational. Psychogenic ED often has a sudden onset, and men with psychogenic ED tend to have more difficulty sustaining than achieving an erection.[1]
The diagnosis of ED begins with a comprehensive evaluation including medical, sexual, and psychosocial history, a physical examination of genitourinary anatomy, and laboratory testing to rule out other conditions. Diagnosis and assessment of ED are also conducted using validated questionnaires such as the International Index of Erectile Function (IIEF), which assesses a patient’s response to various treatment strategies. The IIEF classifies ED into five categories: no ED (score of 22–25), mild ED (score of 17–21), mild-moderate ED (score of 12–16), moderate ED (score of 8–11), and severe ED (score of 1–7).[4]
In certain cases, specialized diagnostic testing, including vascular testing using ultrasound, nocturnal penile tumescence (NPT), erection rigidity testing, and neuropsychological testing, may be performed.[5]
The first-line therapy for ED is the use of a phosphodiesterase-5 inhibitor (PDE5I), of which sildenafil (Viagra), tadalafil, vardenafil, and avanafil are the most commonly prescribed. PDE5I in combination with prescription testosterone therapy has also been effective in improving ED symptoms.[6]
Other treatments for ED include the application of vasodilators like alprostadil (topical, intraurethral, or intracavernosal), low-intensity extracorporeal shockwave therapy (Li-ESWT), vacuum erection devices, testosterone therapy (intramuscular or transdermal), psychosexual counseling,cognitive behavioral therapy (CBT), vascular surgery, and the use of penile prostheses (inflatable or semirigid devices). Among these, the strongest evidence supports CBT (often in combination with PDE5Is), intracavernous alprostadil injections, and penile prosthesis implantation.[7]
Ginseng appears to have trivial effects on erectile function, but may improve men’s self-reported ability to have intercourse and their satisfaction with intercourse.[11] Saffron (Crocus sativus),[12] Tribulus terrestris,[13] Pycnogenol (Pinus pinaster),[14] Maca (Lepidium meyenii),[15] and Tongkat Ali (Eurycoma longifolia)[16] also appear to improve ED symptoms, though there are only a few studies to support each of these herbs.[17]
Supplementing with L-Arginine (alone or combined with L-Citrulline, Pycnogenol, ornithine, or yohimbine) improves erectile function.[18] Yohimbine, especially when combined with L-Arginine, also improves ED symptoms, but doesn’t seem to increase sexual function.[19] L-Citrulline (a precursor to L-Arginine) has also been shown in one study to improve erection hardness in men with ED.[20]
The Mediterranean diet, plant-based diets, and diets containing high amounts of fruits and vegetables, nuts, legumes, fish, whole grains, antioxidants, and omega-3 fatty acids and lower amounts of red and processed meat, trans fat, dairy, sugar, sodium, and alcohol are associated with a lower risk of ED.[21][22][23][24][25][26][27]
However, some studies suggest that any association between the type of diet one follows (i.e., Mediterranean, low-fat, low-carbohydrate, ketogenic, vegetarian/vegan, pescatarian) and ED disappears when controlling for age, BMI, and other risk factors.[28][29] Weight loss achieved through a low-fat, low-calorie diet;[30][31], a high-protein, low-carbohydrate diet;[32] a high-protein, low-fat diet; or a high-carbohydrate, low-fat diet[33] improves erectile function in men with diabetes and/or overweight/obesity.
Weight loss, whether achieved through diet and/or physical activity[34][35][36] or through bariatric surgery,[37] improves ED in men with overweight or obesity.
Physical inactivity increases the risk for ED,[38][39] while exercise — particularly moderate- to vigorous-intensity aerobic exercise — improves erectile function in men with ED and comorbidities including obesity, metabolic syndrome, and cardiovascular disease.[40][41] In fact, a 2019 review indicated that among all ED treatments, physical activity interventions caused the largest improvement in ED, with effectiveness similar to pharmacological therapy.[42]
Other emerging yet experimental ED treatments include gene therapy, stem cell therapy,[43][44] Li-ESWT,[45][46][45] platelet-rich plasma (PRP), low-intensity pulsed ultrasound (LIPUS), hyperbaric oxygen therapy, penile vibratory stimulation,[47][48] and pelvic floor muscle training.[49].
At its core, ED is caused by a deficit in NO release, cyclic GMP (cGMP) and calcium signaling, or smooth muscle relaxation. However, many overlapping mechanisms can interrupt this signaling cascade.
Psychogenic or sympathetic-mediated ED is caused by stress, depression, or anxiety about sexual performance. Neurogenic ED is caused by a deficit in nerve signaling to the penis, which may be secondary to spinal cord injury, traumatic brain injury, or surgery. Vasculogenic ED — the most common form of ED — is caused by underlying vascular disease, endothelial dysfunction, and structural changes to the arterial walls. Iatrogenic ED is most often the result of pelvic surgery or the use of medications. Finally, endocrine causes of ED include low levels of androgens (e.g., testosterone) and other hormones.
A number of medications have been linked to ED, including antihypertensives (blood pressure medications); 5𝛼-reductase inhibitors, anti-androgens, luteinizing hormone-releasing agonists and antagonists (used to treat prostate cancer), antidepressant medications, and opiates.[1]
References
Examine Database References
- Erections - GamalEl Din SF, Abdel Salam MA, Mohamed MS, Ahmed AR, Motawaa AT, Saadeldin OA, Elnabarway RRTribulus terrestris versus placebo in the treatment of erectile dysfunction and lower urinary tract symptoms in patients with late-onset hypogonadism: A placebo-controlled studyUrologia.(2018 Sep 25)
- Erections - Roaiah MF, El Khayat YI, GamalEl Din SF, Abd El Salam MAPilot Study on the Effect of Botanical Medicine (Tribulus terrestris) on Serum Testosterone Level and Erectile Function in Aging Males With Partial Androgen Deficiency (PADAM)J Sex Marital Ther.(2016 May 18)
- Erections - Kamenov Z, Fileva S, Kalinov K, Jannini EAEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction-A prospective, randomized, double-blind, placebo-controlled clinical trialMaturitas.(2017 May)
- Erections - Petre GC, Francini-Pesenti F, Vitagliano A, Grande G, Ferlin A, Garolla ADietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use.Nutrients.(2023-Aug-22)
- Erections - Ali Shamsa, Hossein Hosseinzadeh, Mahmood Molaei, Mohammad Taghi Shakeri, Omid RajabiEvaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot studyPhytomedicine.(2009 Aug)
- Erections - Modabbernia A, Sohrabi H, Nasehi AA, Raisi F, Saroukhani S, Jamshidi A, Tabrizi M, Ashrafi M, Akhondzadeh SEffect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trialPsychopharmacology (Berl).(2012 Oct)
- Erections - Maleki-Saghooni N, Mirzaeii K, Hosseinzadeh H, Sadeghi R, Irani MA systematic review and meta-analysis of clinical trials on saffron (Crocus sativus) effectiveness and safety on erectile dysfunction and semen parameters.Avicenna J Phytomed.(2018 May-Jun)
- Erections - Luigi Cormio, Mario De Siati, Fabrizio Lorusso, Oscar Selvaggio, Lucia Mirabella, Francesca Sanguedolce, Giuseppe CarrieriOral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunctionUrology.(2011 Jan)
- Erections - Kim TH, Jeon SH, Hahn EJ, Paek KY, Park JK, Youn NY, Lee HLEffects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunctionAsian J Androl.(2009 May)
- Erections - Giorgio Cavallini, Fabio Modenini, Giovanni Vitali, Aleardo KoverechAcetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomyUrology.(2005 Nov)
- Erections - D Gianfrilli, R Lauretta, C Di Dato, C Graziadio, C Pozza, J De Larichaudy, E Giannetta, A M Isidori, A LenziPropionyl-L-carnitine, L-arginine and niacin in sexual medicine: a nutraceutical approach to erectile dysfunctionAndrologia.(2012 May)
- Erections - Zenico T, Cicero AF, Valmorri L, Mercuriali M, Bercovich ESubjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trialAndrologia.(2009 Apr)
- Erections - Kotirum S, Ismail SB, Chaiyakunapruk NEfficacy of Tongkat Ali (Eurycoma longifolia) on erectile function improvement: systematic review and meta-analysis of randomized controlled trials.Complement Ther Med.(2015-Oct)
- Erections - Zhang Y, Zhang W, Dai Y, Jiang H, Zhang XSerum Folic Acid and Erectile Dysfunction: A Systematic Review and Meta-Analysis.Sex Med.(2021-Jun)
- Testosterone - Conaglen HM, Suttie JM, Conaglen JVEffect of deer velvet on sexual function in men and their partners: a double-blind, placebo-controlled studyArch Sex Behav.(2003 Jun)
- Penile Girth - Harte CB, Meston CMAcute effects of nicotine on physiological and subjective sexual arousal in nonsmoking men: a randomized, double-blind, placebo-controlled trialJ Sex Med.(2008 Jan)